CompoAtlas

Lutein Capsule

Natural health product licensed in Canada

Licence holder
Aersun Technology Ltd.
NPN or DIN-HM
80085035
Status
Active licence
Licence date
9 May 2018
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Officinale

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Esters de lutéine

Source : Tagetes erecta - Oléorésine (herbe en fleurs)

25 milligrammeNot calculated
Esters de zéaxanthine

Source : Tagetes erecta - Oléorésine (herbe en fleurs)

5 milligrammeNot calculated

Non-medicinal ingredients

Eau purifiée, Stéarate de magnésium, Cellulose microcristalline, Gélatine, Dioxyde de titane

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years1 Capsule1 Tous les jours

Uses authorised in Canada

Provides antioxidants for the maintenance of eye health. Helps to support eye health in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to reduce the risk of developing cataracts. Helps to improve macular pigment optical density.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80085035

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line